Biotechnology News and Research

RSS

Innate immune priming may evolve into a broadly applicable infection-prevention strategy

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine.

16 Feb 2026

Novel antibody 007 targets the elusive HIV envelope epitope

HIV-1 can be neutralized by antibodies which bind to vulnerable structures on the virus surface. One such vulnerable site is the so-called V3 glycan site of the viral envelope protein.

13 Feb 2026

Shared brainwave biomarker bridges mouse and human fragile X research

Numerous potential treatments for neurological conditions, including autism spectrum disorders, have worked well in lab mice but then disappointed in humans.

11 Feb 2026

Study uncovers how bacterial circadian clocks control gene expression

Our circadian clocks play a crucial role in our health and well-being, keeping our 24-hour biological cycles in sync with light and dark exposure.

10 Feb 2026

AI model accelerates antibody production and clone selection

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

9 Feb 2026

Newly identified protein interaction fine-tunes cellular stress responses

Cornell researchers have discovered a new way cells regulate how they respond to stress, identifying an interaction between two proteins that helps keep a critical cellular recycling system in balance.

9 Feb 2026

Engineered enzyme enables fast and accurate RNA synthesis

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine.

9 Feb 2026

New nanoparticle separation method boosts biotech and cancer research

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves particle separation and purification.

9 Feb 2026

Groundbreaking trial aims for precise dietary data collection

Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in their daily lives.

9 Feb 2026

Mycoprotein demonstrates strong potential for sustainable nutrition

Plant-based food as an alternative to meat is high on the agenda today, and mycoprotein (fungal protein) in particular has come into focus in recent years.

6 Feb 2026

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.

5 Feb 2026

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.

5 Feb 2026

Small molecule targets glioblastoma oncogene in preclinical studies

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest brain cancer.

4 Feb 2026

Australian researchers develop a new way to target deadly, drug-resistant bacteria

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells – an advance that could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.

4 Feb 2026

Scientists create new map showing how cancer gene mutations influence tumor growth

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth.

2 Feb 2026

New platform improves prediction of human antibody drug responses

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The

1 Feb 2026

Early TB treatment before sepsis diagnosis could save countless lives

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are diagnosed with TB – could save countless lives, the researchers say.

30 Jan 2026

Aptamer-based wearables revolutionize continuous health tracking

Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood sampling. Recent advances in aptamer-based wearable electrochemical sensors offer a promising alternative by enabling real-time, continuous tracking of physiological signals directly in or on the body.

30 Jan 2026

UVA Health scientists pioneer a new way to create vaccines far more quickly than ever before

UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly and inexpensively than ever before.

28 Jan 2026

Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetes

More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and reduce risks for T2D and its complications.

28 Jan 2026